Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.

Haematologica - 1 Jul 2022

Kudo Ko, Toki Tsutomu, Kanezaki Rika, Tanaka Tatsuhiko, Kamio Takuya, Sato Tomohiko, Sasaki Shinya, Imamura Masaru, Imai Chihaya, Ando Kumiko, Kakuda Harumi, Doi Takehiko, Kawaguchi Hiroshi, Irie Masahiro, Sasahara Yoji, Tamura Akihiro, Hasegawa Daiichiro, Itakura Yosuke, Watanabe Kenichiro, Sakamoto Kenichi, Shioda Yoko, Kato Motohiro, Kudo Kazuko, Fukano Reiji, Sato Atsushi, Yagasaki Hiroshi, Kanegane Hirokazu, Kato Itaru, Umeda Katsutsugu, Adachi Souichi, Kataoka Tatsuki, Kurose Akira, Nakazawa Atsuko, Terui Kiminori, Ito Etsuro

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Bone Marrow Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histiocytosis, Langerhans-Cell

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 35295077
DOI: 10.3324/haematol.2021.279857
PMCID: PMC9244822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.PMID 35295077Read ↗

Advances in our understanding of genetic markers and targeted therapies for pediatric LCH.Semantic proximity Read ↗

BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy.Semantic proximity Read ↗

The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis.Semantic proximity Read ↗

Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E.Semantic proximity Read ↗

BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis.Semantic proximity Read ↗

Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.Semantic proximity Read ↗

BRAF-V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitorSemantic proximity Read ↗

Cytogenetic abnormalities in Langerhans cell histiocytosisSemantic proximity Read ↗

VE1 immunohistochemistry to determine BRAFV600E mutation in Langerhans-cell histiocytosis.Semantic proximity Read ↗

Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosisSemantic proximity Read ↗

[Expression and clinical significance of BRAF V600E in children with Langerhans cell histiocytosis].Semantic proximity Read ↗

Immunophenotyping of congenital leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.